D-Series Webinar: Tamir Meiri,Johnson & Johnson Innovation

Tamir Meiri will cover how Johnson & Johnson Venture Investments invests and supports globally to bring strategic value to companies and patients to improve health outcomes worldwide using creative investments and diverse experiences.

About the Speaker:

Tamir Meiri, MBA, Director, Johnson & Johnson Venture Investments

With over a decade of experience in venture capital investment, Tamir is responsible for identifying and leading medical device, consumer and health technology investments in line with Johnson & Johnson sector strategies. This includes deal sourcing, due diligence, negotiation, structuring, decision making, execution, and post-investment portfolio management.

Covering West North America, Australia & New Zealand, Tamir is an engaged, hands-on investor who likes to be detail-oriented and involved in his companies. He aims to help young entrepreneurs maximize their potential by providing meaningful advice and empowerment through close relationships and personal commitment to the people and companies in JJDC's portfolio.

Prior to joining JJDC, Tamir worked at GKH Law Offices – one of the largest law firms in Israel, supporting the firm's managing partners for over six years in many aspects of the various deal processes, including marketing and business development.

Tamir has a B.Sc in Chemistry from Tel-Aviv University and an extensive background in biomedical engineering and entrepreneurship, as well as an MBA with a major in Finance, from the Interdisciplinary Center in Herzliya.